Akshay Kanakan

FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip

Manoj Kumar, Sneha Gulati, Asgar Hussain Ansari et al. · eLife · 2021 · 85 citations · Full text

Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial

Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay et al. · 2020 · 58 citations · Full text

Viral Diagnostics, Immunodeficiencies, Passive Immunization +17

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay et al. · Nature Communications · 2022 · 40 citations · Full text

COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefits

Shanmukh Alle, Akshay Kanakan, Samreen Siddiqui et al. · PLoS ONE · 2022 · 32 citations · Full text

Mortality Prediction, Prognosis, Covid-19 Risk Stratification +21

Increased Abundance of Achromobacter xylosoxidans and Bacillus cereus in Upper Airway Transcriptionally Active Microbiome of COVID-19 Mortality Patients Indicates Role of Co-Infections in Disease Severity and Outcome

Priti Devi, Ranjeet Maurya, Priyanka Mehta et al. · Microbiology Spectrum · 2022 · 29 citations · Full text